Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

Nektar Therapeutics (NKTR) Jumps: Stock Rises 10.54%

Nektar Therapeutics NKTR was a big mover last session, as the company saw its shares rise nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $23.02 to $29.25 in the past one-month time frame.

The move came after the company reported solid third-quarter 2017 results.

The company has seen four positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Nektar Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Nektar Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Nektar Therapeutics Price

A better-ranked stock in the Medical sector is Sucampo Pharmaceuticals, Inc. SCMP, which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is NKTR going up? Or down? Predict to see what others think: Up or Down.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Sucampo Pharmaceuticals, Inc. (SCMP): Free Stock Analysis Report
 
Nektar Therapeutics (NKTR): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research